Page 3 - Patanjali Ayurved Ramdev

What is the Magic Remedies Act under which Patanjali is facing scrutiny

Everything you need to know on the false advertisement case against Patanjali and the implications of the Drugs and Magic Remedies Act, 1954

Patanjali Foods sheds 5% on SC notice to promoter firm for misleading advts

The Supreme Court on Tuesday issued a contempt notice to Patanjali Ayurved and its MD Acharya Balakrishna for flouting earlier orders by continuing to propagate misleading claims via advertisements.

Entire country is taken for a ride: SC contempt notice to Patanjali on ads

Misleading ads banned, Centre told to list out steps against false claims

'Sitting with eyes closed': SC rebukes Centre over misleading Patanjali ads

The Supreme Court had warned Patanjali Ayurved against disseminating 'false' and 'misleading' claims in its advertisements

Not making false ad, ready for death sentence if found guilty: Patanjali

Baba Ramdev-led Patanjali Ayurved on Wednesday said it was not making any "false advertisements or propaganda" regarding its products, and said it would not object if the Supreme Court were to impose a fine or "even give us a death sentence" if found making misleading claims. A day after the apex court cautioned the company against making "false" and "misleading" claims in advertisements about its medicines as cure of several diseases, Patanjali Ayurved said it has "database with more than one crore people, with real world evidence, preclinical and clinical evidence". "Patanjali have made thousands of people free from several diseases like BP, sugar, thyroid, asthma, arthritis, obesity, liver and kidney failure, and cancer," the company asserted. The company further said, "We humbly respect the Supreme Court of India and if we make false advertisements or propaganda, we would not have any objections if honourable court imposes a fine of crores or even give us a death sentence." On

SC cautions Patanjali over making 'false' claims about its medicines in ads

The Supreme Court Tuesday cautioned Patanjali Ayurved, a company co-founded by yoga guru Ramdev and dealing in herbal products, against making "false" and "misleading" claims in advertisements about its medicines as cure of several diseases. "All such false and misleading advertisements of Patanjali Ayurved have to stop immediately. The court will take any such infraction very seriously...," a bench comprising justices Ahsanuddin Amanullah and Prashant Kumar Mishra orally observed while hearing a plea of the Indian Medical Association (IMA). The top court, on August 23, 2022, had issued notices to the Union health ministry and Ministry of Ayush and Patanjali Ayurved Ltd, on the plea of the IMA alleging a smear campaign by Ramdev against the vaccination drive and modern medicines. During the brief hearing, the bench asked Patanjali Ayurved not to publish misleading claims and advertisements against modern systems of medicine. It said the bench may also consider imposing a fine of Rs

Patanjali's OFS for non-retail investors oversubscribed 2 times on Day 1

Baba Ramdev-led Patanjali Ayurved's offer to sell shares of Patanjali Foods received good response on Thursday, with the portion set aside for non-retail investors getting subscribed more than two times. The two-day Offer For Sale (OFS) has been launched by promoter entity Patanjali Ayurved to pare its total stake in Patanjali Foods by around 7 per cent to meet the minimum public shareholding requirement. The offer received cumulative bids for over 4.56 crore shares, translating into 2 times subscriptions, according to BSE data. On Thursday only 2.28 crore shares were offered for sale to non-retail investors. Retail investors will bid on Friday. Patanjali Ayurved received bids for 1,20,27,936 shares (with 100 per cent margin), while bids for 3,36,04,276 shares were received at nil margin. Shares of Patanjali Foods fell 5 per cent to Rs 1,166.65 on the BSE. On Wednesday, Patanjali Foods had informed that its promoter Patanjali Ayurved will sell up to 2.53 crore shares in its group

Patanjali preparing to regain toothpaste mkt, expand distribution channels

Patanjali is strengthening its distribution system by expanding it from the current one million outlets to about 1.5 million outlets

Nepal blacklists 16 Indian pharma companies, including Ramdev's Pharmacy

Nepal's drug regulatory authority has blacklisted 16 Indian pharmaceutical companies, including Divya Pharmacy which manufactures Yoga Guru Ramdev's Patanjali products, stating that they failed to comply with the World Health Organisation's (WHO) drug manufacturing standards. The Department of Drug Administration, in a notice issued on December 18 asked the local agents in Nepal, which have been supplying these medicines, to immediately recall them. According to the notice issued by the Department, the medicines manufactured by the listed companies cannot be imported or distributed in Nepal. The list of the companies that do not comply with WHO standards were published after inspection of the manufacturing facilities of the pharmaceutical companies that had applied to export their products to Nepal, according to the Department officials. In April and July, the Department sent a team of drug inspectors to India to inspect the manufacturing facilities of pharmaceutical companies that

Delhi HC to hear plea against Ramdev for remarks against allopathy

The Delhi High Court will hear on Monday a plea by seven doctors' associations against Yoga guru Ramdev for allegedly spreading misinformation by his statements against allopathy amid the ongoing COVID-19 pandemic. The matter will be heard by Justice C Hari Shankar who had earlier asked the counsel for the associations to place on record the videos pertaining to the alleged misinformation. The associations before court are three Resident Doctors' Association of the All India Institute of Medical Sciences at Rishikesh, Patna and Bhubaneshwar, Association of Resident Doctors, Post Graduate Institute of Medical Education & Research, Chandigarh, Union of Resident Doctors of Punjab (URDP); Resident Doctors' Association, Lala Lajpat Rai Memorial Medical College, Meerut and Telangana Junior Doctors' Association, Hyderabad. They alleged that Ramdev was misleading and misrepresenting to the public at large that allopathy was responsible for the deaths of several people infected by ...

Patanjali Ayurved raises Rs 175 cr through non-convertible debentures

Baba Ramdev-led Patanjali Ayurved on Tuesday said it has raised Rs 175 crore by issuing non-convertible debentures (NCDs).

Top headlines: GST cut for auto sector unlikely, Happiest Minds IPO shines

Business Standard brings you the top headlines of the day

From Patanjali's claim to U-turn on Coronil: Sequence of events

On June 23, Baba Ramdev-led Patanjali Ayurved launched a medicine, 'Coronil', for treating Covid-19 in just seven days

Ruchi Soya soared 90 times in 5 months; should you buy?

From Rs 16.9 to Rs 1,519 in five months, the stock has seen a spectacular rise of 8,988 per cent

Rajasthan cops charge Ramdev, Patanjali MD with cheating for Covid-19 drug

Haridwar-based Patanjali Ayurved on Tuesday launched "Coronil", claiming it can cure COVID-19

Coronavirus updates: Over 17,000 new cases, record recoveries in India

India death toll crosses 15,000; Maharashtra, Delhi, Tamil Nadu account for 68% of cases added today

Amid 'Coronil' row, Ramdev's Patanjali insists it broke no regulations

The Haridwar-based company on Tuesday launched "Coronil", claiming it can cure Covid-19

India-US 'green' corridor for air travel, and other coronavirus updates

The total number of Covid-19 cases in Delhi crossed the 66,000 mark, with the biggest single-day spike of 3,947 fresh infections being reported on Tuesday

Good that Ramdev has given Covid-19 medicine, but rules matter: Minister

The Ministry had also issued a notification in April stating the requirements and the manner in which the research studies on Covid-19 with AYUSH interventions/medicines should be undertaken

Govt asks Ramdev's Patanjali group to stop Covid-19 drug ads, seeks details

Hours after the launch, the ministry denied knowledge of the drugs and asked the group to refrain from publicising them.